NIFTY LABS

Nifty Labs, a Hyderabad-based manufacturer established in 2005, has been granted Certificates of Suitability (CEP) from the EDQM for a range of products including lansoprazole, rabeprazole sodium, aripiprazole, quetiapine fumarate, esomeprazole magnesium trihydrate, doxazosin mesylate and rivaroxaban. The company maintains Drug Master Files in eCTD format for many APIs and advanced intermediates, with DMF registrations at global regulatory authorities including SFDA, KFDA and TFDA, reflecting its commitment to international regulatory standards. Selling into North America, Eastern Europe, Australasia, Asia and the Middle East under its own brand with 60-day payment terms, Nifty Labs counts major pharmaceutical companies such as Teva, KRKA, Genfar and Apex Pharma among its customers, and is recognized for international approvals, an experienced R&D staff, reliable delivery, production capacity, a large product line and strong industry reputation.